Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients

被引：0
|
作者：
Malgorzata Banys-Paluchowski
Karin Milde-Langosch
Tanja Fehm
Isabell Witzel
Leticia Oliveira-Ferrer
Barbara Schmalfeldt
Volkmar Müller
机构：
[1] Asklepios Klinik Barmbek,Department of Gynecology and Obstetrics
[2] University Medical Center Hamburg-Eppendorf,Department of Gynecology
[3] University of Düsseldorf,Department of Gynecology and Obstetrics
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Breast cancer; RAS gene; Survival; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：403 / 414
页数：11
相关论文
共 50 条
  • [1] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Banys-Paluchowski, Malgorzata
    Milde-Langosch, Karin
    Fehm, Tanja
    Witzel, Isabell
    Oliveira-Ferrer, Leticia
    Schmalfeldt, Barbara
    Mueller, Volkmar
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (02) : 403 - 414
  • [2] N-RAS, H-RAS, AND K-RAS - A DIFFERENCE IN TRANSFORMING POTENTIAL
    MAHER, J
    BAKER, DA
    DIBB, NJ
    ROBERTS, IAG
    [J]. BLOOD, 1994, 84 (10) : A295 - A295
  • [3] ANALYSIS OF H-RAS, K-RAS AND N-RAS GENES FOR EXPRESSION, MUTATION AND AMPLIFICATION IN LARYNGEAL TUMORS
    KIARIS, H
    SPANDIDOS, DA
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 75 - 80
  • [4] H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers
    Przybojewska, B
    Jagiello, A
    Jalmuzna, P
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) : 73 - 77
  • [5] EVIDENCE FOR CELL-SPECIFIC DIFFERENCES IN TRANSFORMATION BY N-RAS, H-RAS AND K-RAS
    MAHER, J
    BAKER, DA
    MANNING, M
    DIBB, NJ
    ROBERTS, IAG
    [J]. ONCOGENE, 1995, 11 (08) : 1639 - 1647
  • [6] Mutation and expression analysis of K-Ras, H-Ras, N-Ras and B-Raf oncogenes in Wilms tumors
    Dalpa, Efterpi
    Gourvas, Victor
    Soulitzis, Nikolaos
    Spandidos, Demetrios A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S93 - S93
  • [7] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [8] Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors
    Vageli, D
    Kiaris, H
    Delakas, D
    Anezinis, P
    Cranidis, A
    Spandidos, DA
    [J]. CANCER LETTERS, 1996, 107 (02) : 241 - 247
  • [9] The K-Ras, N-Ras, and H-Ras Isoforms: Unique Conformational Preferences and Implications for Targeting Oncogenic Mutants
    Parker, Jillian A.
    Mattos, Carla
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [10] K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
    Dalpa, Efterpi
    Gourvas, Victor
    Soulitzis, Nikolaos
    Spandidos, Demetrios A.
    [J]. MEDICAL ONCOLOGY, 2017, 34 (01)
12345